South Korea's Exports Hit Record High in March on AI-Driven Chip Demand 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
Goldman Sachs Sees Value in European Real Estate Stocks Despite Sharp Selloff 
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
U.S. Stocks Surge on Iran War De-escalation Hopes 
Canada's Economy Grows Modestly in January 2025, Driven by Energy and Construction 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Japan's Business Confidence Rises Despite Iran War Uncertainty, BOJ Rate Hike Expected 
A kind of paracetamol being marketed under the brand name Paraveganio is now available in Germany. What makes this medicine special is the fact that it is made with plant-based ingredients only, and it is the first of its kind in the world.
PlantBased News reported that the new medicinal drug is now vegan-certified and the world’s first to be registered with The Vegan Trademark, a trusted vegan labeling being managed by The Vegan Society, a recognized charity and the oldest vegan organization in the world.
Paraveganio was developed by a German pharma firm called Axunio. It was made using 100% plant-based ingredients, and it is now the first product to be certified as vegan by The Vegan Society. Paracetamol is used worldwide as a painkiller and can be purchased over-the-counter, but this medicine contains an animal-derived additive called the magnesium stearate.
Most pharma companies use this additive for lubricating properties in tablets and capsules. The stearic acid that it contains is an ingredient that is made with animal fats.
The plant-based Paraveganio paracetamol is free from magnesium stearate sourced from animals. Rather, this was taken from pure vegetable sources. Axunio guaranteed that its 500 mg. paracetamol tablets are 100% vegan drug that can be taken to relieve mild and moderate pain as well as reduce fever.
“We could not be prouder to be bringing the world’s first vegan-certified drug to the market. Of course, to have it certified by The Vegan Society’s Vegan Trademark – the gold standard in vegan labeling - makes it that much more special too,” Axunio’s product and business development manager, Julia von Horsten, said in a press release.
She added, “Many people are surprised to hear that the majority of medications, including over-the-counter products such as paracetamol, contain animal derivatives or have been tested on animals. We know there’s a gap in the market for vegan certified paracetamol and are so delighted to be able to offer our product to consumers.”
Meanwhile, this is a good innovation, but the Paraveganio tablets are only available in Germany at the moment. Then again, this may soon reach other countries as Axunio is planning to bring its vegan paracetamol to other markets too.
